Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting.

Ghosh SC, Rodriguez M, Carmon KS, Voss J, Wilganowski NL, Schonbrunn A, Azhdarinia A.

J Nucl Med. 2017 Nov;58(11):1858-1864. doi: 10.2967/jnumed.116.187971. Epub 2017 Jun 1.

2.

Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque.

Powell DR, Gay JP, Smith M, Wilganowski N, Harris A, Holland A, Reyes M, Kirkham L, Kirkpatrick LL, Zambrowicz B, Hansen G, Platt KA, van Sligtenhorst I, Ding ZM, Desai U.

Diabetes Metab Syndr Obes. 2016 Jun 22;9:185-99. doi: 10.2147/DMSO.S106653. eCollection 2016.

3.

Diacylglycerol Lipase α Knockout Mice Demonstrate Metabolic and Behavioral Phenotypes Similar to Those of Cannabinoid Receptor 1 Knockout Mice.

Powell DR, Gay JP, Wilganowski N, Doree D, Savelieva KV, Lanthorn TH, Read R, Vogel P, Hansen GM, Brommage R, Ding ZM, Desai U, Zambrowicz B.

Front Endocrinol (Lausanne). 2015 Jun 2;6:86. doi: 10.3389/fendo.2015.00086. eCollection 2015.

4.

The camKK2/camKIV relay is an essential regulator of hepatic cancer.

Lin F, Marcelo KL, Rajapakshe K, Coarfa C, Dean A, Wilganowski N, Robinson H, Sevick E, Bissig KD, Goldie LC, Means AR, York B.

Hepatology. 2015 Aug;62(2):505-20. doi: 10.1002/hep.27832. Epub 2015 May 9.

5.

Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.

Ghosh SC, Pinkston KL, Robinson H, Harvey BR, Wilganowski N, Gore K, Sevick-Muraca EM, Azhdarinia A.

Nucl Med Biol. 2015 Feb;42(2):177-83. doi: 10.1016/j.nucmedbio.2014.09.009. Epub 2014 Oct 5.

PMID:
25457653
6.

Deglycosylation of mAb by EndoS for improved molecular imaging.

Gao P, Pinkston KL, Wilganowski N, Robinson H, Azhdarinia A, Zhu B, Sevick-Muraca EM, Harvey BR.

Mol Imaging Biol. 2015 Apr;17(2):195-203. doi: 10.1007/s11307-014-0781-9.

PMID:
25135058
7.

Targeting pili in enterococcal pathogenesis.

Pinkston KL, Singh KV, Gao P, Wilganowski N, Robinson H, Ghosh S, Azhdarinia A, Sevick-Muraca EM, Murray BE, Harvey BR.

Infect Immun. 2014 Apr;82(4):1540-7. doi: 10.1128/IAI.01403-13. Epub 2014 Jan 22.

8.

In vivo imaging of orthotopic prostate cancer with far-red gene reporter fluorescence tomography and in vivo and ex vivo validation.

Lu Y, Darne CD, Tan IC, Wu G, Wilganowski N, Robinson H, Azhdarinia A, Zhu B, Rasmussen JC, Sevick-Muraca EM.

J Biomed Opt. 2013 Oct;18(10):101305. doi: 10.1117/1.JBO.18.10.101305.

9.

Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.

Zhu B, Wu G, Robinson H, Wilganowski N, Hall MA, Ghosh SC, Pinkston KL, Azhdarinia A, Harvey BR, Sevick-Muraca EM.

Mol Imaging Biol. 2013 Oct;15(5):560-8. doi: 10.1007/s11307-013-0637-8.

PMID:
23619897
10.

Multimodal chelation platform for near-infrared fluorescence/nuclear imaging.

Ghosh SC, Ghosh P, Wilganowski N, Robinson H, Hall MA, Dickinson G, Pinkston KL, Harvey BR, Sevick-Muraca EM, Azhdarinia A.

J Med Chem. 2013 Jan 24;56(2):406-16. doi: 10.1021/jm300906g. Epub 2013 Jan 8.

PMID:
23214723
11.

Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.

Hall MA, Pinkston KL, Wilganowski N, Robinson H, Ghosh P, Azhdarinia A, Vazquez-Arreguin K, Kolonin AM, Harvey BR, Sevick-Muraca EM.

J Nucl Med. 2012 Sep;53(9):1427-37. doi: 10.2967/jnumed.112.106302. Epub 2012 Aug 7.

12.

Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis.

Azhdarinia A, Ghosh P, Ghosh S, Wilganowski N, Sevick-Muraca EM.

Mol Imaging Biol. 2012 Jun;14(3):261-76. doi: 10.1007/s11307-011-0528-9. Review.

13.

Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.

Davies-Venn CA, Angermiller B, Wilganowski N, Ghosh P, Harvey BR, Wu G, Kwon S, Aldrich MB, Sevick-Muraca EM.

Mol Imaging Biol. 2012 Jun;14(3):301-14. doi: 10.1007/s11307-011-0499-x.

14.

Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide.

Azhdarinia A, Wilganowski N, Robinson H, Ghosh P, Kwon S, Lazard ZW, Davis AR, Olmsted-Davis E, Sevick-Muraca EM.

Bioorg Med Chem. 2011 Jun 15;19(12):3769-76. doi: 10.1016/j.bmc.2011.04.054. Epub 2011 May 6.

15.

Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model.

Rodenberg E, Azhdarinia A, Lazard ZW, Hall M, Kwon SK, Wilganowski N, Salisbury EA, Merched-Sauvage M, Olmsted-Davis EA, Sevick-Muraca EM, Davis AR.

Tissue Eng Part A. 2011 Oct;17(19-20):2487-96. doi: 10.1089/ten.TEA.2011.0007. Epub 2011 Aug 2.

PMID:
21599541
16.

GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.

Sonnenburg WK, Yu D, Lee EC, Xiong W, Gololobov G, Key B, Gay J, Wilganowski N, Hu Y, Zhao S, Schneider M, Ding ZM, Zambrowicz BP, Landes G, Powell DR, Desai U.

J Lipid Res. 2009 Dec;50(12):2421-9. doi: 10.1194/jlr.M900145-JLR200. Epub 2009 Jun 21.

17.

Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).

Lee EC, Desai U, Gololobov G, Hong S, Feng X, Yu XC, Gay J, Wilganowski N, Gao C, Du LL, Chen J, Hu Y, Zhao S, Kirkpatrick L, Schneider M, Zambrowicz BP, Landes G, Powell DR, Sonnenburg WK.

J Biol Chem. 2009 May 15;284(20):13735-45. doi: 10.1074/jbc.M807899200. Epub 2009 Mar 23.

18.

Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice.

Desai U, Lee EC, Chung K, Gao C, Gay J, Key B, Hansen G, Machajewski D, Platt KA, Sands AT, Schneider M, Van Sligtenhorst I, Suwanichkul A, Vogel P, Wilganowski N, Wingert J, Zambrowicz BP, Landes G, Powell DR.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11766-71. Epub 2007 Jul 3.

19.

Phenotypic changes in Arabidopsis caused by expression of a yeast vacuolar Ca2+/H+ antiporter.

Hirschi KD, Miranda ML, Wilganowski NL.

Plant Mol Biol. 2001 May;46(1):57-65.

PMID:
11437250
20.

Expression of arabidopsis CAX2 in tobacco. Altered metal accumulation and increased manganese tolerance.

Hirschi KD, Korenkov VD, Wilganowski NL, Wagner GJ.

Plant Physiol. 2000 Sep;124(1):125-33.

Supplemental Content

Loading ...
Support Center